Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Reata Pharmaceuticals, Inc. Class A Common Stock | RETA

Daily Technical Analysis of Reata Pharmaceuticals, Inc. Class A Common Stock

There wasn't too much excitement in Reata Pharmaceuticals today which only managed to move up 0.40% on the day.

The Biotechnology company isn't at an immediate support or resistance level that might be predictive. Reata Pharmaceuticals has looked pretty good over the last few months. It has definitely cuaght a bid and had a nice run. Over the last 3 months, shareholders are no doubt pleased to see a 146.67 percent return. RETA might find some support at the 35.4 level, buyers might push the price back up from here. But it's not very clear what will happen.


Analyst Ratings for Reata Pharmaceuticals By Price Target And Rating

The analysts feel pretty optimistic about Reata Pharmaceuticals and have been assigning positive ratings. The current Analysts Sentiment Score is 250.34. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. On 2023-03-01 Barclays increased their price target by 80% to $90.00. Cantor Fitzgerald boosted their price targ by 98.36% to $121.00 on 2023-03-01. On 2023-03-01 Citigroup increased their price target by 126.42% to $120.00. On 2023-03-01 Stifel Nicolaus increased their price target by 40% to $105.00. Robert W. Baird provided a price target boost of 112.5% to $85.00 from $40.00 on 2023-03-01. SVB Securities gave a boost to their price target and moved to $75.00 from $35.00 on 2023-03-01. On 2023-02-24 The Goldman Sachs Group increased their price target by 1.74% to $117.00. Guggenheim initiated a rating of Buy on 2022-10-19 and they set their price target at $75.00.LADENBURG THALM/SH SH provided a price target decease of -10.67% to $67.00 from $75.00 on 2022-05-11. On 2021-12-09 there was confirmation of the previous rating by SVB Leerink which was Outperform and dropped their 1 year price target to $35.00 which is down from $282.00.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
RETA250.3418.17-0.52484.65-1.61

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2022-11-28)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
RETA0.042.10

Short interest for Reata Pharmaceuticals

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
RETA17.64%26.110.4-4.4887320000

How Reata Pharmaceuticals compares to the broader Healthcare sector and the more specific Biotechnology industry

Segment Count 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Analysts Ratings ?
Biotechnology

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
3671.85-0.88-10.561.85-7.04-22.1531.57-13.77-17.27-13.81-41814.93-3164.240.9521.196.5448.84
Healthcare

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
6172.00-0.17-8.492.07-6.13-23.9331.85-11.33-14.45-14.07-36805.91-4054.411.0522.335.9336.37

Social Sentiment for Reata Pharmaceuticals

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
RETA10.00

Companies with the highest correlation to Reata Pharmaceuticals

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
MRTX | Mirati Therapeutics, Inc.0.210.47-5.68-11.54-6.28-46.20-50.9930-14.19-41.95-45.08-40206.42177.83012516.0654
AVAV | AeroVironment, Inc.0.210.080.677.479.811.67-3.89598.055.837.45-210.34-7150.75004.66932
ICPT | Intercept Pharmaceuticals0.21-5.65-8.80-26.975.35-20.55-13.79412.7817.5534.25-5212.80-2211.56008.37277
WING | Wingstop Inc0.20.155.603.1026.9737.3457.483761.2890.1575.22-1978.24-9300.26006.62829
RDNT | RadNet, Inc. Common Stock0.190.382.5811.9822.3921.837.054447.1223.6323.49-1122.90-7620.85004.276
DMTK | DermTech, Inc. Common Sto0.198.54-1.66-14.4297.78-23.61-72.9136-8.15-7.92-7.98-28468.77-1130.76007.53122

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-